Evidence map

SynthesisInternal and emergency medicine2026

Efficacy of tirzepatide, lanifibranor, and resmetirom in metabolic dysfunction-associated steatotic liver disease: a meta-analysis of high-quality randomized controlled trials.

Shuai Zhao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2026
this papercites it

5 trials

Full record →Abstract, authors, funding and every citing paper · PMID 41917519